Skip to main content
. 2016 Nov 21;5(2):171–186. doi: 10.1007/s40122-016-0062-1

Fig. 1.

Fig. 1

Photograph showing the spherical, microparticulate nature of oxycodone DETERx capsule contents. Republished with the permission of Weston Medical Publishing, LLC, from the article “Impact of physical manipulation on in vitro and in vivo release profiles of oxycodone DETERx: an extended-release, abuse-deterrent formulation” (Kopecky EA et al. Journal of Opioid Management 2014;10(4):233–246); permission conveyed through Copyright Clearance Center, Inc. [23]